Year: 2024 | Month: July-September | Volume: 9 | Issue: 3 | Pages: 281-289
DOI: https://doi.org/10.52403/ijshr.20240334
Mitigating Social and Economic Burdens: The Role of Genomic Diagnosis and Sequencing in Enhancing Cancer Management in India
Shyla Sama
Student at, The Shri Ram School, Moulsari
ABSTRACT
Cancer misdiagnosis and mistreatment in India present significant challenges, not only for patients and their families but also for society and the economy as a whole. These issues lead to substantial negative externalities, including a deadweight loss caused by the misallocation of vital healthcare resources. However, advancements in genomic diagnosis and sequencing offer promising potential for improving the accuracy of cancer detection and treatment. This paper explores the field of genomic medicine and evaluates its effectiveness in India, with a focus on how advancements in the country's biotechnology industry can help reduce the socio-economic costs currently borne by the nation.
Keywords: Genomic Medicine, Genomic Diagnosis, Genomic Sequencing, Cancer, India, Socio-economic Costs, Externalities, Biotechnology